Growth failure and outcomes in infants with biliary atresia: A report from the Biliary Atresia Research Consortium Potential conflict of interest: Dr. Shneider is on the speakers' bureau of Axcan Scandipharm. Dr. Schwarz received grants from Roche and Gilead.

Deep Blue Home

Show full item record

Accessibility: If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.

This item appears in the following Collection(s)

Search Deep Blue

Browse by

My Account


Coming Soon

MLibrary logo